DiscoverHematopoiesis: An ASH Trainee Council ProductionBench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies
Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies

Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies

Update: 2022-12-02
Share

Description

In the second episode of this Hematopoiesis Bench to Bedside series, Dr. Manuel Espinoza-Gutarra has conversations with Dr. Aaron Mitchell, Dr. Yousuf Zafar (@yzafar), Dr. Aju Mathew, and Dr. Nandita Khera (@khera_nandita), experts in the field of financial toxicity in cancer patients, who offer different perspectives regarding the impact of the financial costs of modern anticancer treatment puts on patients, how should we adequately measure it and how to tackle it.

Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies

Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies

American Society of Hematology